Introduction
Percutaneous needle biopsy is commonly used in the investigation of pulmonary nodules that are unlikely to be visualised bronchoscopically.' Most clinicians use some form of fine gauge needle to provide a sample, which is adequate for microbiological and cytological examination but rarely for histological examination. To assess the role of this technique in the management of patients with solitary pulmonary nodules, we have reviewed our experience retrospectively and determined the diagnostic yield and accuracy of cytology in our unit.
Methods
The records of all patients undergoing percutaneous needle biopsy at tological examination of surgical or necropsy specimens were noted. Biopsies were performed by a consultant radiologist or radiologists in training; they used a fine gauge (20 G or 22 G) aspirating needle or a 21 G Rotex screw biopsy needle (Ursus Konsult) and the material obtained was used to make a cytology smear preparation. One to three passes were made, the number depending on the appearance ofthe smear and the ease with which the lesion was sampled. All biopsies were of intrapulmonary masses that measured I cm or more in diameter on the chest radiograph. Fluoroscopic guidance was used as described previously.2 The material obtained was examined by the same cytopathologist (VB) and classified as being malignant, as showing a specific benign condition such as a hamartoma, or as showing "no evidence of malignancy." Tumours were subdivided into five groups: (I) squamous carcinoma; (2) adenocarcinoma; (3) undifferentiated tumour; (4) small cell tumours; (5) other tumours.
Any tumour that could not be specifically typed was classified as an undifferentiated tumour. 968 patients over a nine year period. Figure 1 s5 the fate of all patients in this study. ) diagnosis of malignancy was made fron biopsy in 473 patients (69% Penketh, Robinson, Barker, Flower ummarises performed on 10 patients with inoperable lesions, so A positive that 150 cases diagnosed as malignant by needle n the first biopsy had histological material for comparison with '3 patients, cytological specimens. There were three false positives:
were con-patients with a pseudolymphoma and an eosinophilic unction, or granuloma were misdiagnosed as having undifferenbsequently tiated carcinoma from the cytological specimens and a pulmonary infarct was misdiagnosed as squamous carcinoma. An inadequate specimen was obtained from two patients (0 3%), in whom the procedure was not repeated as the original radiographic abnormalities resolved. A definite diagnosis of a benign condition was made by needle biopsy in 10 patients (I -5% Table 2 compares the cell type reports on cytological specimens from the first needle biopsy of malignant lesions compared with the subsequent histological diagnosis based on thoracotomy or necropsy material There was agreement in 91 of the 150 cases (61 %) overall. Cytology was most accurate in the diagnosis of adenocarcinoma, 17 out of 20 patients being diagnosed correctly (85%); the other patients had a squamous cell carcinoma (1) or rare tumours (2). Sixty seven per cent of those reported as having squamous cell carcinomas were diagnosed correctly from cytology specimens, the other 32 patients having adenocarcinoma (24), undifferentiated tumours (2), anaplastic tumours (2), clear cell tumours (2), transitional cell carcinoma (1), and a pulmonary infarct. Nineteen tumours were classified cytologically as undifferentiated but only one (5%) was confirmed as such from histological appearances. The other 18 patients had squamous cell carcinoma (7), adenocarcinoma (6), benign lesions (2), and rare tumours (3). Cytology was poor for diagnosing small cell carcinoma of the bronchus; offour cases with this cytological diagnosis, only one had the diagnosis confirmed histologically and a further histologically proved case had been diagnosed as lymphosarcoma by cytology. Nine out of 10 other specific tumours were correctly diagnosed by cytology.
REPEAT NEEDLE BIOPSIES
A second needle biopsy was performed in 43 of the 198 patients with no evidence of malignancy from the first biopsy. The yield of malignancy at the second biopsy was 37% (16 cases, three confirmed at thoracotomy).
There was no evidence of malignancy in 27 patients, six ofwhom were subsequently found to have cancer at thoracotomy, necropsy, or further lung biopsy (fig 2) .
The false negative rate for the second biopsy was 14%.
Discussion
Percutaneous aspiration needle biopsy of the lung has become more widely used with the advent of fluoroscopy and image intensification.3 A limited amount of material is obtained, which is usually adequate only for microbiological or cytological examination. The latter may be technically difficult if the sample is distorted in the process of biopsy or during the preparation of the specimen, so that appearances may differ from those seen in exfoliative cytological preparations.4
The usefulness of this technique in the investigation of pulmonary nodules depends on the ability to differentiate between benign and malignant lesions, thereby obviating the need for an exploratory thoracotomy. In this series a specific benign diagnosis was made in only 10 patients (1 -5%). This figure may be artificially low as most patients with infections, many of whom are immunosuppressed, are inves- In summary, our results suggest that, if a positive diagnosis of malignancy or of a specific benign condition is made cytologically from a percutaneous needle biopsy specimen of a pulmonary nodule, the result is reliable. A non-specific negative result, however, cannot be relied on.
The second role for needle biopsy in the investigation of pulmonary nodules is to provide a histological diagnosis on the basis of which a decision can be made about palliative treatment in those patients with cancer for whom surgery is not an option. Payne et aP showed that needle biopsy material is not as accurate at predicting cell type as other biopsy material. In their large study there was agreement of needle biopsy cytology with histology in 62%, similar to the 61% in the present series (the patients in the present series seen during 1976-79 are included in the series of Payne et al). Only 150 of the 473 cases with a needle biopsy cytology report of malignancy, however, had histological material available for comparison in the present series, 32% of the group. There is obviously room for error if the distribution of cell type in this subgroup is not representative ofthe group as a whole. Table 3 shows the distribution of the cell type of tumour diagnosed at cytology in the whole group of 473 patients and the subgroup of 150 who later had surgery or necropsy. In the latter group there is a higher percentage of squamous cell carcinoma and a lower percentage ofadenocarcinoma than in the group as a whole. One major error of cytology compared with histology was the misdiagnosis of adenocarcinoma as squamous cell carcinoma. The other error was in misdiagnosis of squamous cell carcinoma or adenocarcinoma as undifferentiated tumour. The proportion of undifferentiated tumours and small cell tumours diagnosed cytologically was relatively constant in the two groups. Rudd et all'0 compared the accuracy of diagnosis of small cell tumours by needle and bronchial biopsy techniques and found that it was reliable by both methods. We have found, however, that needle biopsy cytology is not accurate in the diagnosis of small cell carcinoma, although our group with this cell type was extremely small. 
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